title: Letter by Papageorgiou et al regarding article, "OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction".
authors: Nikolaos
authors: N
authors: Papageorgiou
authors: Dimitris
authors: D
authors: Tousoulis
authors: Christodoulos
authors: C
authors: Stefanadis
mesh_terms: D016757:Death, Sudden, Cardiac / Q000517:prevention & control*; D004032:Diet; D004305:Dose-Response Relationship, Drug; D023381:Endpoint Determination; D019317:Evidence-Based Medicine; D015525:Fatty Acids, Omega-3 / Q000627:therapeutic use*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D018799:Intercellular Adhesion Molecule-1 / Q000097:blood; D009203:Myocardial Infarction / Q000097:blood / Q000534:rehabilitation / Q000628:therapy*; D009204:Myocardial Revascularization; D016032:Randomized Controlled Trials as Topic; D055502:Secondary Prevention; D013997:Time Factors; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000097:blood
chemical_list: D015525:Fatty Acids, Omega-3; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D014409:Tumor Necrosis Factor-alpha; D018799:Intercellular Adhesion Molecule-1